Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00775216 · ClinicalTrials.gov registry record · NA

Project Diabetes: Prescription for Healthy Living

A NA study, sponsored by Vanderbilt University.

Terminated
Registry status
NA
Development phase
13
Enrollment target

NCT00775216 is a NA study that was terminated before completion, run by Vanderbilt University. The registered enrollment target is 13 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00775216, a NA study, was terminated before completion, sponsored by Vanderbilt University.

TERMINATED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Health disparities related to obesity, pre-diabetes and Type 2 diabetes in the United States represent public health concerns. Given the benefit of exercise in disease prevention and management, evidence-based, cost-effective, brief interventions are needed to improve patient outcomes related to Type 2 diabetes and associated conditions. This novel behavioral intervention study connects individuals with resources within their community to affect change in their health and wellness. The aim is to connect disparate individuals to health and wellness resources to prevent the onset of diabetes. This will be accomplished through a collaborative effort with Vanderbilt Diabetes Center, Nashville Metro Parks and Recreation, and the Metro Public Health Department. A time series design will be used to assess the efficacy of physical activity counseling delivered by a health care professional, plus continued contact intervention delivered via a proactive and reactive health promotion counseling hotline that will leverage our partnership with Metro Parks versus counseling advice alone. In order to refine this intervention (Phase II) before it is executed, focus groups will first be conducted in Phase I with members of the target population in order to obtain feedback on the proposed intervention activities and materials. Qualitative findings and feasibility testing will be the basis for modifying the intervention.

Interventions

  • BEHAVIORAL Behavioral counseling plus "telephone helpline"

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2008-10
Est. Completion 2009-11
Phase NA

Sponsor

Vanderbilt University

430 total trials

What the Registry Record Tells You About NCT00775216

The ClinicalTrials.gov registry entry for NCT00775216 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Behavioral counseling plus "telephone helpline" is the first listed.

NCT00775216 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00775216 about?

NCT00775216 is a clinical study titled "Project Diabetes: Prescription for Healthy Living". Health disparities related to obesity, pre-diabetes and Type 2 diabetes in the United States represent public health concerns. Given the benefit of exercise in disease prevention and management, evidence-based, cost-effective, brief interventions are needed to improve patient outcomes related to Typ...

What is the current status of trial NCT00775216?

This trial is currently terminated. It is a NA study. The enrollment target is 13 participants. The study started on 2008-10. Estimated completion is 2009-11.

What interventions are being tested in trial NCT00775216?

The interventions under investigation include: Behavioral counseling plus "telephone helpline" (BEHAVIORAL).

Who is sponsoring clinical trial NCT00775216?

This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.